a, a N Clinical Trials

A listing of a, a N clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1923 clinical trials
Current and Past SARS-CoV-2 Infection and COVID-19 in Healthcare

The SARS-CoV-2 pandemic and resulting COVID-19 disease causes a substantial burden on healthcare systems. Little is known about how the infection spreads within healthcare. In order to design control strategies, knowledge of the presence of viral nucleic acid and whether an immune response to the virus has been mounted is …

SARS
acute respiratory syndrome (sars)
throat
  • 0 views
  • 19 Feb, 2024
  • 1 location
SARS-CoV-2 Disguise Study

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is a pandemic disease with worldwide spreading. Limited data are existed regarding SARS-CoV-2 positive carriers among asymptomatic medical employees in non-profile infectious clinic, e.g. cardiovascular clinic, routinely working in the pandemic region with two million inhabitants.

oropharyngeal
coronavirus infection
acute respiratory syndrome (sars)
SARS
  • 0 views
  • 19 Feb, 2024
  • 1 location
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)

In the last 5 years there has been remarkable progress in identifying genetic variants that affect risk of CAD, with much of this work being co-led from Leicester. These discoveries provide a framework for testing whether the addition of genetic information in the form of a genetic risk score can …

coronary disease
cardiovascular disease
arteriopathy
  • 0 views
  • 19 Feb, 2024
  • 1 location
Prediction of Therapeutic Response of Apatinib in Recurrent Gliomas

Apatinib, also known as YN968D1, is a small-molecule tyrosine kinase inhibitor (TKI) that selectively binds to and inhibits vascular endothelial growth factor receptor 2 (VEGFR-2).

tyrosine
liver metastasis
vascular endothelial growth factor receptor 2
metastasis
neutrophil count
  • 0 views
  • 19 Feb, 2024
  • 1 location
HeartStart FRx Defibrillator Event Registry

This post market clinical follow-up study is a multi-center, non-randomized, unblinded, observational registry of the performance of the FRx Automated external defibrillator (AED) used in conjunction with electrodes with or without use of the infant/child key.

defibrillation
shock
circulatory arrest
  • 0 views
  • 19 Feb, 2024
  • 1 location
Spontaneous Coronary Artery Dissection National Swiss Registry

Despite recent improvements in diagnosis and recognition of the importance of SCAD, it remains poorly studied and understood. In this context, we designed the SwissSCAD registry, a large, observational, prospective, cohort study, to describe the natural history of SCAD, its outcomes and its treatments.

  • 0 views
  • 19 Feb, 2024
  • 1 location
DeBakey Cardiovascular Magnetic Resonance Study

The aim of this large prospective registry revolves around 4 key principles: 1) utilize CMR to gain additional pathophysiologic insights into cardiovascular disease, 2) understand how CMR compares to alternative cardiovascular diagnostic modalities, 3) determine how CMR affects clinical management decisions, and 4) establish a link between CMR findings and …

heart disease
cardiovascular disease
vascular disease
  • 0 views
  • 19 Feb, 2024
  • 1 location
French Observatory of ElectroConvulsive Therapy (ECT)

Since the 30s, ECT has been a psychiatric treatment mainly used for drug-resistant depressive illnesses. Clinical studies have shown its therapeutic efficiency compared to standard treatments also in other psychiatric illnesses.

psychiatric treatment
psychiatric disorder
psychiatric care
electroconvulsive treatment
  • 0 views
  • 19 Feb, 2024
  • 1 location
Mucopolysaccharidosis I (MPS I) Registry

The objectives of the Registry are: To evaluate the long-term effectiveness and safety of Aldurazyme (laronidase) To characterize and describe the MPS I population as a whole, including the variability, progression, and natural history of MPS I To help the MPS I medical community with the development of recommendations for …

  • 0 views
  • 19 Feb, 2024
  • 136 locations
Pompe Disease Registry

The objectives of the Registry are: To enhance the understanding of the variability, progression, and natural history of the key manifestations of Pompe disease; To assist the Pompe medical community with the development of recommendations for monitoring patients and reports on patient outcomes to help optimize patient care; To characterize …

replacement therapy
glycogen storage disease type ii
gaa gene
myozyme
deficiency
  • 0 views
  • 19 Feb, 2024
  • 191 locations